Is SPDR S&P Pharmaceuticals ETF halal to invest in?

As of September 2026, SPDR S&P Pharmaceuticals ETF XPH is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is SPDR S&P Pharmaceuticals ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes SPDR S&P Pharmaceuticals ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for SPDR S&P Pharmaceuticals ETF updated?

The Shariah compliance status of SPDR S&P Pharmaceuticals ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like SPDR S&P Pharmaceuticals ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of SPDR S&P Pharmaceuticals ETF?

You can check the latest Shariah compliance status of SPDR S&P Pharmaceuticals ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

SPDR S&P Pharmaceuticals ETF XPH

XPH Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, SPDR S&P Pharmaceuticals ETF is classified as not halal.

NOT HALAL

Is SPDR S&P Pharmaceuticals ETF Halal?

Shariah Compliance Analysis of XPH ETF

US Equity Health Care

No. As of September 2026, SPDR S&P Pharmaceuticals ETF (XPH) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. SPDR S&P Pharmaceuticals ETF does not pass Musaffa's business and financial screening criteria.

XPH was created on 2006-06-19 by SPDR. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 231.58m in AUM and 60 holdings. XPH tracks an equal-weighted index of US pharmaceutical companies.

SPDR S&P Pharmaceuticals ETF (XPH) Chart

Key Statistics of SPDR S&P Pharmaceuticals ETF (XPH)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
99.84%
Other
0.16%

FAQ's for SPDR S&P Pharmaceuticals ETF (XPH)

As of September 2026, SPDR S&P Pharmaceuticals ETF XPH is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes SPDR S&P Pharmaceuticals ETF using these criteria to determine its compliance status.
The Shariah compliance status of SPDR S&P Pharmaceuticals ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of SPDR S&P Pharmaceuticals ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.